Apoptosis inhibitor 5 increases metastasis via Erk-mediated MMP expression
1
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Apoptosis inhibitor 5 (API5) has recently been identified as a tumor metastasis-regulating gene in cervical cancer cells. However, the precise mechanism of action for API5 is poorly understood. Here, we show that API5 increases the metastatic capacity of cervical cancer cells in vitro and in vivo via up-regulation of MMP-9. Interestingly, API5-mediated metastasis was strongly dependent on the Erk signaling pathway. Conversely, knock-down of API5 via siRNA technology decreased the level of phospho-Erk, the activity of the MMPs, in vitro invasion, and in vivo pulmonary metastasis. Moreover, the Erk-mediated metastatic action was abolished by the mutation of leucine into arginine within the heptad leucine repeat region, which affects protein-protein interactions. Thus, API5 increases the metastatic capacity of tumor cells by up-regulating MMP levels via activation of the Erk signaling pathway.
Abstract
Apoptosis inhibitor 5 (API5) has recently been identified as a tumor metastasis-regulating gene in cervical cancer cells. However, the precise mechanism of action for API5 is poorly understood. Here, we show that API5 increases the metastatic capacity of cervical cancer cells in vitro and in vivo via up-regulation of MMP-9. Interestingly, API5-mediated metastasis was strongly dependent on the Erk signaling pathway. Conversely, knock-down of API5 via siRNA technology decreased the level of phospho-Erk, the activity of the MMPs, in vitro invasion, and in vivo pulmonary metastasis. Moreover, the Erk-mediated metastatic action was abolished by the mutation of leucine into arginine within the heptad leucine repeat region, which affects protein-protein interactions. Thus, API5 increases the metastatic capacity of tumor cells by up-regulating MMP levels via activation of the Erk signaling pathway.
참고문헌 (14)
- Tewari M, "AAC-11, a novel cDNA that inhibits apoptosis after growth factor withdrawal", Cancer Res, 57, pp.4063~4069 (1997)
- Koci L, "Apoptosis inhibitor 5(API-5; AAC-11; FIF)is upregulated in human carcinomas in vivo", Oncology Lett, 3, pp.913~916 (2012)
- Morris L, "Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300", CBP co-activators, 2000, pp.2, 232~239
- Garcia-Jove Navarro M, "Api5 contributes to E2F1 control of the G1", S cell cycle phase transition, 2013, pp.8, e71443~
- Ren K, "Pim-2 activates API-5 to inhibit the apoptosis of hepatocellular carcinoma cells through NF-kappaB pathway", Pathol Oncol Res, 16, pp.229~237 (2010)
- , a nuclear putatively antiapoptotic factor, interacts specifically with FGF-2, "Mol Endocrinol", 2000, 1709~1724
- Gianfrancesco F, "Molecular cloning and fine mapping of API5L1, a novel human gene strongly related to an antiapoptotic gene", Cytogenet Cell Genet, 84, pp.164~166 (1999)
- Morris EJ, "Functional identification of Api5 as a suppressor of E2F-dependent apoptosis in vivo", PLoS Genet, 2, pp.e196~ (2006)
- Chung TW, "Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism", FASEB J, 18, pp.1670~1681 (2004)
- Han BG, "Helical repeat structure of apoptosis inhibitor 5 reveals protein-protein interaction modules", J Biol Chem, 287, pp.10727~10737 (2012)
- Rigou P, "The antiapoptotic protein AAC-11 interacts with and regulates Acinusmediated DNA fragmentation", EMBO J, 28, pp.1576~1588 (2009)
- Tseng HC, "IL-1beta promotes corneal epithelial cell migration by increasing MMP-9 expression through NF-kappaB-and AP-1-dependent pathways", PLoS One, 8, pp.e57955~ (2013)
- Simon C, "The p38 SAPK pathway regulates the expression of the MMP-9 collagenase via AP-1-dependent promoter activation", Exp Cell Res, 271, pp.344~355 (2001)
- Wang Y, "Activation of the c-fos enhancer by the Erk MAP kinase pathway through two sequence elements: the c-fos AP-1 and p62TCF sites", Oncogene, 19, pp.1379~1385 (2000)